# Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy

> **NCT00559481** · NA · WITHDRAWN · sponsor: **Roswell Park Cancer Institute**

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** dexamethasone
- **DRUG:** ketoconazole
- **DRUG:** therapeutic hydrocortisone
- **PROCEDURE:** pharmacological study

## Key facts

- **NCT ID:** NCT00559481
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-10
- **Primary completion:** 2008-09
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawn due to low accrual
- **Last updated:** 2013-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00559481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00559481, "Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00559481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*